Simon R - Search Results

1

Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer.

Lebok P, Huber J, Burandt EC, Lebeau A, Marx AH, Terracciano L, Heilenkötter U, Jänicke F, Müller V, Paluchowski P, Geist S, Wilke C, Simon R, Sauter G, Quaas A. Lebok P, et al. Among authors: simon r. Mol Med Rep. 2016 Aug;14(2):1443-50. doi: 10.3892/mmr.2016.5430. Epub 2016 Jun 23. Mol Med Rep. 2016. PMID: 27357606 Free PMC article.

2

Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.

Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G. Simon R, et al. Oncogene. 2002 Apr 11;21(16):2476-83. doi: 10.1038/sj.onc.1205304. Oncogene. 2002. PMID: 11971182

3

Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study.

Kocher T, Zheng M, Bolli M, Simon R, Forster T, Schultz-Thater E, Remmel E, Noppen C, Schmid U, Ackermann D, Mihatsch MJ, Gasser T, Heberer M, Sauter G, Spagnoli GC. Kocher T, et al. Among authors: simon r. Int J Cancer. 2002 Aug 20;100(6):702-5. doi: 10.1002/ijc.10540. Int J Cancer. 2002. PMID: 12209610

4

Tissue microarrays for miniaturized high-throughput molecular profiling of tumors.

Simon R, Sauter G. Simon R, et al. Exp Hematol. 2002 Dec;30(12):1365-72. doi: 10.1016/s0301-472x(02)00965-7. Exp Hematol. 2002. PMID: 12482497 Free article. Review.

5

Predictive molecular pathology.

Sauter G, Simon R. Sauter G, et al. Among authors: simon r. N Engl J Med. 2002 Dec 19;347(25):1995-6. doi: 10.1056/NEJMp020155. N Engl J Med. 2002. PMID: 12490679 No abstract available.

6

Tissue microarrays in cancer diagnosis.

Simon R, Mirlacher M, Sauter G. Simon R, et al. Expert Rev Mol Diagn. 2003 Jul;3(4):421-30. doi: 10.1586/14737159.3.4.421. Expert Rev Mol Diagn. 2003. PMID: 12877382 Review.

7

Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays.

Pache M, Glatz K, Bösch D, Dirnhofer S, Mirlacher M, Simon R, Schraml P, Rufle A, Flammer J, Sauter G, Meyer P. Pache M, et al. Among authors: simon r. Virchows Arch. 2003 Dec;443(6):741-4. doi: 10.1007/s00428-003-0883-2. Epub 2003 Sep 26. Virchows Arch. 2003. PMID: 14513377

8

HER-2 and TOP2A coamplification in urinary bladder cancer.

Simon R, Atefy R, Wagner U, Forster T, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T, Sauter G. Simon R, et al. Int J Cancer. 2003 Dec 10;107(5):764-72. doi: 10.1002/ijc.11477. Int J Cancer. 2003. PMID: 14566826

9

Tissue microarrays in drug discovery.

Sauter G, Simon R, Hillan K. Sauter G, et al. Among authors: simon r. Nat Rev Drug Discov. 2003 Dec;2(12):962-72. doi: 10.1038/nrd1254. Nat Rev Drug Discov. 2003. PMID: 14654795 Review. No abstract available.

10

KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations.

Simon R, Panussis S, Maurer R, Spichtin H, Glatz K, Tapia C, Mirlacher M, Rufle A, Torhorst J, Sauter G. Simon R, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):178-83. doi: 10.1158/1078-0432.ccr-0597-3. Clin Cancer Res. 2004. PMID: 14734467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,204 results

Search Page

Filters